Diligence memo · auto-generated · as of July 2, 2026
Jade Therapeutics, Inc.
Jade Therapeutics, Inc. looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Jade Therapeutics, Inc. operates in Biotechnology, based in SALT LAKE CITY.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Jade Therapeutics, Inc. has raised $1.4M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $800K on —.
Valuation (modeled)modeled
Provath models Jade Therapeutics, Inc. at approximately $1.1M (range $427K–$2.0M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.10× the median modeled value of Pre-Seed Biotechnology companies (927 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
No dated round to assess.
The last round was 1.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 22% of Biotechnology peers (4293 compared).
Modeled value ranks above 3% of those peers.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.